Neurological Sciences

, Volume 40, Issue 2, pp 405–407 | Cite as

The performance of patients with Parkinson’s disease on the Face-Name Associative Memory Examination

  • Constantinos KormasEmail author
  • Ioannis Zalonis
  • Ioannis Evdokimidis
  • Constantin Potagas
Brief Communication


In this study, we examined the performance of patients with Parkinson’s disease (PD) with different cognitive profiles on the Face-Name Associative Memory Examination (FNAME). We evaluated 71 patients with a comprehensive neuropsychological battery. The results revealed that the group with executive and additional visuospatial deficits demonstrated significantly lower scores on FNAME. This finding indicates the possible clinical utility of FNAME for screening patients with PD with distinct cognitive profiles. Further longitudinal studies are needed to consider the prognostic adequacy of FNAME in detecting high-risk Parkinson’s disease dementia (PDD).


Face-Name Associative Memory Examination Parkinson’s disease Cognitive impairment Visuospatial functions Executive functions 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The Ethics Committee of Aeginition Hospital, National and Kapodistrian University of Athens, approved the study protocol using the principles outlined in the Declaration of Helsinki.

Informed consent

All participants were informed of the study purpose, and they signed a written informed consent form before they participated.


  1. 1.
    Pagonabarraga J, Kulisevsky J (2012) Cognitive impairment and dementia in Parkinson's disease. Neurobiol Dis 46:590–596CrossRefGoogle Scholar
  2. 2.
    Aarsland D, Kurz MW (2010) The epidemiology of dementia associated with Parkinson’s disease. Brain Pathol 20:633–639CrossRefGoogle Scholar
  3. 3.
    Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, Brayne C, Kolachana BS, Weinberger DR, Sawcer SJ, Barker RA (2009) The distinct cognitive syndromes of Parkinson’s disease: 5 year follow-up of the CamPaIGN cohort. Brain 132:2958–2969CrossRefGoogle Scholar
  4. 4.
    Kehagia AA, Barker RA, Robbins TW (2013) Cognitive impairment in Parkinson’s disease: the dual syndrome hypothesis. Neurodegener Dis 11:79–92CrossRefGoogle Scholar
  5. 5.
    Irwin DJ, White MT, Toledo JB, Xie SX, Robinson JL, van Deerlin V, Lee VMY, Leverenz JB, Montine TJ, Duda JE, Hurtig HI, Trojanowski JQ (2012) Neuropathologic substrates of Parkinson disease dementia. Ann Neurol 72:587–598CrossRefGoogle Scholar
  6. 6.
    Rentz DM, Amariglio RE, Becker JA, Frey M, Olson LE, Frishe K, Carmasin J, Maye JE, Johnson KA, Sperling RA (2011) Face-name associative memory performance is related to amyloid burden in normal elderly. Neuropsychol 49(9):2776–2783CrossRefGoogle Scholar
  7. 7.
    Sanabria A et al (2018) The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in subjective cognitive decline. Sci Rep 8(1):3828CrossRefGoogle Scholar
  8. 8.
    Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699CrossRefGoogle Scholar
  9. 9.
    Konstantopoulos K, Vogazianos P, Doskas T (2016) Normative data of the Montreal Cognitive Assessment in the Greek population and parkinsonian dementia. Arch Clin Neuropsychol 31(3):246–253CrossRefGoogle Scholar
  10. 10.
    Partington JE, Leiter RG (1949) Partington’s pathway test. Psychol Service Center Bull 1:9–20Google Scholar
  11. 11.
    Zalonis I, Kararizou E, Triantafyllou NI, Kapaki E, Papageorgiou S, Sgouropoulos PEEA, Vassilopoulos D (2008) A normative study of the trail making test A and B in Greek adults. Clin Neuropsychol 22:842–850CrossRefGoogle Scholar
  12. 12.
    Zalonis et al (2009) The stroop effect in Greek healthy population: normative data for the stroop neuropsychological screening test. Arch Clin Neuropsychol 24:81–88CrossRefGoogle Scholar
  13. 13.
    Rey A (1941) L’examen psychologique dans les cas d’encephalopathie traumatique (Les problems.). Archives de Psychologie 28:215–285Google Scholar
  14. 14.
    Aretouli E, Kosmidis MH (2007) Rey–Osterrieth Complex Figure Test: Greek norms and cultural and demographic influences. Paper accepted to the 9th European Conference on Psychological Assessment & 2nd International Conference of the Psychological Society of Northern GreeceGoogle Scholar
  15. 15.
    Kormas C, Megalokonomou A, Zalonis I, Evdokimidis I, Kapaki E, Potagas C (2018) Development of the Greek version of the Face Name Associative Memory Exam (GR-FNAME12) in cognitively normal elderly individuals. Clin Neuropsychol 2:1–12. CrossRefGoogle Scholar
  16. 16.
    Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27(3):349–356CrossRefGoogle Scholar
  17. 17.
    Biundo R, Weis L, Antonini A (2016) Cognitive decline in Parkinson’s disease: the complex picture. NPJ Parkinsons Dis 2:16018CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  1. 1.First Department of Neurology, Aeginition HospitalNational and Kapodistrian University of AthensAthensGreece

Personalised recommendations